Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRH Regulatory News (CRH)

Share Price Information for CRH (CRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,298.00
Bid: 6,294.00
Ask: 6,298.00
Change: -68.00 (-1.07%)
Spread: 4.00 (0.064%)
Open: 6,334.00
High: 6,356.00
Low: 6,296.00
Prev. Close: 6,366.00
CRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update to Share Buyback Programme

28 Dec 2018 07:00

RNS Number : 6131L
CRH PLC
28 December 2018
 

Press Release

CRH Completes Phase 3 and Announces Phase 4 of Share Buyback Programme

 

On 25 April 2018, CRH plc announced its intention to repurchase ordinary shares of up to €1 billion over the next 12 months. CRH is pleased to announce that it has completed the third phase of its share buyback programme, returning a further €100 million of cash to shareholders (the "Phase 3 Programme").

 

Between 27 November 2018 and 21 December 2018, 4.1 million ordinary shares were repurchased on the London Stock Exchange. This brings total cash returned to shareholders under the ongoing €1 billion share buyback programme to €800 million.

 

CRH today also announces that it has entered into arrangements with UBS A.G., London Branch ("UBS") to repurchase ordinary shares on CRH's behalf for a maximum consideration of €200 million (the "Phase 4 Programme").

 

The Phase 4 Programme will commence on 2 January 2019, and will end no later than 29 March 2019. This will complete the €1 billion share buyback programme as announced on 25 April 2018.

 

Under the terms of the Phase 4 Programme, ordinary shares will be repurchased on the London Stock Exchange and/or Euronext Dublin. CRH has entered into non-discretionary instructions with UBS to conduct the Phase 4 Programme on its behalf and to make trading decisions under the Phase 4 Programme independently of CRH in accordance with certain pre-set parameters.

 

The Phase 4 Programme, the purpose of which is to reduce the share capital of CRH, will be conducted within the limitations of the authority granted at CRH's AGM on 26 April 2018 to repurchase up to 10% of the Company's ordinary shares in issue (being 56,199,571 ordinary shares following the completion of the first, second and third phases of the buyback programme).

 

The Phase 4 Programme will also be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 and Chapter 12 of the UK Listing Rules. The repurchased ordinary shares will be held in treasury pending their cancellation or re-issue in due course.

 

This announcement relates solely to the completion of the Phase 3 Programme and the commencement of the Phase 4 Programme and any decision in relation to any future buyback programmes will be based on an ongoing assessment of the capital needs of the business and general market conditions by the CRH Board of Directors.

 

****

 

Contact CRH at Dublin 404 1000 (+353 1 404 1000)

 

Albert Manifold

Chief Executive

Senan Murphy

Finance Director

Frank Heisterkamp

Head of Investor Relations

 

 

About CRH

CRH (LSE: CRH, ISE: CRG, NYSE: CRH) is a leading global diversified building materials group, employing 85,000 people at over 3,600 operating locations in 32 countries worldwide. CRH is the second largest building materials company worldwide and the largest in North America. The Group has leadership positions in Europe, where it is the largest heavyside materials business, as well as established strategic positions in the emerging economic regions of Asia and South America. CRH is committed to improving the built environment through the delivery of superior materials and products for the construction and maintenance of infrastructure, housing and commercial projects. A Fortune 500 company, CRH is a constituent member of the FTSE 100 index, the EURO STOXX 50 index, the ISEQ 20 and the Dow Jones Sustainability Index (DJSI) Europe. CRH's American Depositary Shares are listed on the New York Stock Exchange (NYSE). CRH's market capitalisation at 30 November 2018 was approximately €20 billion. For more information visit www.crh.com.

 

 

Registered Office: No 12965. Registered Office: 42 Fitzwilliam Square, Dublin 2, R02 R279, Ireland

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCTRBPTMBITBRP
Date   Source Headline
4th Apr 20244:15 pmRNSTransaction in Own Shares
2nd Apr 20244:10 pmRNSBlock listing Interim Review
2nd Apr 20243:08 pmRNSTotal Voting Rights
27th Mar 20245:30 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:30 pmRNSDirector/PDMR Shareholding
20th Mar 20249:30 amRNSTransaction in Own Shares
19th Mar 20249:40 amRNSTransaction in Own Shares
19th Mar 20249:15 amRNSTransaction in Own Shares
15th Mar 20243:15 pmRNSNotice of AGM
15th Mar 20249:30 amRNSTransaction in Own Shares
14th Mar 20249:30 amRNSTransaction in Own Shares
13th Mar 20249:30 amRNSTransaction in Own Shares
12th Mar 20249:15 amRNSTransaction in Own Shares
11th Mar 20249:30 amRNSTransaction in Own Shares
8th Mar 20245:00 pmRNSDirector/PDMR Shareholding
8th Mar 20249:30 amRNSTransaction in Own Shares
7th Mar 20249:30 amRNSTransaction in Own Shares
6th Mar 20248:45 amRNSTransaction in Own Shares
5th Mar 20245:30 pmRNSDirector/PDMR Shareholding
5th Mar 20249:45 amRNSTransaction in Own Shares
4th Mar 20244:00 pmRNSTransaction in Own Shares
4th Mar 20249:45 amRNSTransaction in Own Shares
1st Mar 20243:00 pmRNSTransaction in Own Shares
29th Feb 20243:00 pmRNSTotal Voting Rights
29th Feb 202412:05 pmRNS2023 Annual Report on Form 10-K
29th Feb 20248:45 amRNSTransaction in Own Shares
28th Feb 20249:30 amRNSTransaction in Own Shares
27th Feb 20249:30 amRNSTransaction in Own Shares
26th Feb 20249:30 amRNSTransaction in Own Shares
23rd Feb 20249:30 amRNSTransaction in Own Shares
23rd Feb 20247:05 amRNS5% Preference Shares - Listings Update
22nd Feb 20249:30 amRNSTransaction in Own Shares
21st Feb 20249:30 amRNSTransaction in Own Shares
21st Feb 20247:05 amRNS5% Preference Shares - Listings Update
19th Feb 20249:30 amRNSTransaction in Own Shares
16th Feb 20249:30 amRNSTransaction in Own Shares
15th Feb 20249:30 amRNSTransaction in Own Shares
14th Feb 20249:30 amRNSTransaction in Own Shares
9th Feb 20249:30 amRNSTransaction in Own Shares
8th Feb 20249:30 amRNSTransaction in Own Shares
7th Feb 20243:00 pmRNSTransaction in Own Shares
7th Feb 20249:30 amRNSTransaction in Own Shares
6th Feb 20249:15 amRNSTransaction in Own Shares
5th Feb 202412:30 pmRNSTransaction in Own Shares
2nd Feb 20249:30 amRNSTransaction in Own Shares
1st Feb 20249:00 amRNSTransaction in Own Shares
31st Jan 20242:30 pmRNSTotal Voting Rights
31st Jan 20249:30 amRNSTransaction in Own Shares
30th Jan 20249:30 amRNSTransaction in Own Shares
26th Jan 20243:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.